Latest News

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

Formulary Watch Logo

FDA Accepts Resubmitted BLA for Cosmetic Therapy

My Medical Daily Logo

FDA Accepts Revance Resubmission for Frown Line Therapy

Endpoint News Logo

Will A Biotech Rival Finally Shake Up Abbvie’s $2B Botox Cosmetic Franchise? Revance Will Find Out Soon

Fierce Farma Logo

Revance Set For September FDA Decision on Botox Rival

Plastic Surgery Practice logo

FDA Accepts Revance Resubmission for Frown Line Treatment

Dermatology Times logo

FDA Accepts BLA Resubmission for DAXI Injections

Street Insider Logo

Revance Therapeutics (RVNC) Announces FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines)

Bezinga Logo

Revance Receives FDA Acceptance of BLA Resubmission for DaxiboutlinumtoxinA for Glabellar Lines

Seeking Alpha logo

FDA Accepts Revance Application for Its Injection To Treat Frown Lines

Realself Logo

How Beauty Innovations Are Approved Here and Abroad – Plus the Global Game Changers Doctors are Buzzing About

Allure Logo

What’s The Deal With DAXI, The Neuromodulator Everyone’s Talking About

Nashville Post Logo

Nashville Post: 2022 NAIOP award winners announced